
BASF has dropped its bid for Evonik, saying the specialty chemicals maker’s prospects as an independent business and the risks it faces did not justify a higher valuation. Evonik shares fell as much as 23% after the announcement, while BASF shares rose as much as 2.9% in intraday trading, Der Spiegel reported.
BASF’s last known offer of €24 per share valued Essen-based Evonik at more than €11 billion. BASF said it had signalled a willingness to raise the offer modestly but that Evonik’s board declined to enter more detailed talks, according to Der Spiegel. Evonik wanted to remain independent.
BASF chief executive Markus Kamieth still saw a case for combining the companies. He argued that their businesses complemented each other and that together they could compete more effectively worldwide. For BASF, the sticking point was whether pursuing the deal at a higher price would serve its own shareholders. For Evonik shareholders, the withdrawal changes what the €24 figure means: it marks the last known offer, not a price they can expect BASF to pay.
Sources
- Der Spiegel · Source date: 2026-11-19
Independent editorial content. WUA is not affiliated with any political party. 2026-11-19